Literature DB >> 18504427

Twist and p53 reciprocally regulate target genes via direct interaction.

M Shiota1, H Izumi, T Onitsuka, N Miyamoto, E Kashiwagi, A Kidani, G Hirano, M Takahashi, S Naito, K Kohno.   

Abstract

Twist is basic helix-loop-helix transcription factor that binds to E-boxes in gene promoters. Twist possesses an oncogenic function by interfering with the tumor suppressor function of p53. Using a membrane pull-down assay, we found that Twist directly interacts with p53 and that this interaction underlies the inhibitory effects on p53 target gene expression. Twist interacted with the DNA-binding domain of p53 and suppressed the DNA-binding activity of p53. Transcriptional activation of the p21 promoter by p53 was significantly repressed by the expression of Twist. On the other hand, p53 interacted with the N-terminal domain of Twist and repressed Twist-dependent YB-1 promoter activity. Importantly, we found that p53-dependent growth suppression was canceled by the expression of either Twist or YB-1. Thus, our data suggest that Twist inhibits p53 function via a direct interaction with p53.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504427     DOI: 10.1038/onc.2008.176

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Authors:  Pavlina Dolezelova; Katerina Cetkovska; Karen H Vousden; Stjepan Uldrijan
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

2.  Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Authors:  Ester Sánchez-Tilló; Laura Siles; Oriol de Barrios; Miriam Cuatrecasas; Eva C Vaquero; Antoni Castells; Antonio Postigo
Journal:  Am J Cancer Res       Date:  2011-08-20       Impact factor: 6.166

Review 3.  Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives.

Authors:  Mir Mohd Faheem; Nathan D Seligson; Syed Mudabir Ahmad; Reyaz Ur Rasool; Sumit G Gandhi; Madhulika Bhagat; Anindya Goswami
Journal:  Cell Death Discov       Date:  2020-06-15

4.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

5.  Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer.

Authors:  Ting Ni; Xiao-Yan Li; Na Lu; Teng An; Zhi-Ping Liu; Rong Fu; Wen-Cong Lv; Yi-Wei Zhang; Xiao-Jun Xu; R Grant Rowe; Yong-Shun Lin; Amanda Scherer; Tamar Feinberg; Xiao-Qi Zheng; Bao-An Chen; X Shirley Liu; Qing-Long Guo; Zhao-Qiu Wu; Stephen J Weiss
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

6.  TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Authors:  Michele B Weiss; Ethan V Abel; Melanie M Mayberry; Kevin J Basile; Adam C Berger; Andrew E Aplin
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

7.  Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths.

Authors:  Marjon A Smit; Daniel S Peeper
Journal:  Aging (Albany NY)       Date:  2010-10       Impact factor: 5.682

8.  Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

Authors:  Masaki Shiota; Akira Yokomizo; Yasuhiro Tada; Junichi Inokuchi; Katsunori Tatsugami; Kentaro Kuroiwa; Takeshi Uchiumi; Naohiro Fujimoto; Narihito Seki; Seiji Naito
Journal:  Mol Endocrinol       Date:  2009-11-02

9.  Novel evidence for retinoic acid-induced G (Rig-G) as a tumor suppressor by activating p53 signaling pathway in lung cancer.

Authors:  Junjun Sun; Xuan Wang; Wenfang Liu; Ping Ji; Anquan Shang; Junlu Wu; Hao Zhou; Wenqiang Quan; Yiwen Yao; Yibao Yang; ChenZheng Gu; Zujun Sun; Ajay Goel; Wenhao Weng; Dong Li
Journal:  FASEB J       Date:  2020-08-02       Impact factor: 5.191

10.  Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.

Authors:  X Zhang; W Ma; J Cui; H Yao; H Zhou; Y Ge; L Xiao; X Hu; B-H Liu; J Yang; Y-Y Li; S Chen; C J Eaves; D Wu; Y Zhao
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.